» Articles » PMID: 33139171

Movement Disorders in Chronic Kidney Disease - A Descriptive Review

Overview
Date 2020 Nov 3
PMID 33139171
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The objective of this study is to describe the mechanism of damage to subcortical structures in chronic kidney disease (CKD) and to describe the range of movement disorders associated with CKD.

Materials And Methods: We have reviewed the Medline literature up to January of 2020 using key words movement disorders and chronic kidney disease. The reviewed articles were studied for mechanisms of subcortical damage in CKD as well as type of the reported movements, their frequency and updated treatment.

Results: The search revealed 183 articles most of them dealing with restless legs syndrome. The damage to basal ganglia in CKD resulted from several mechanisms including accumulation of nitro tyrosine caused by reactive oxygen species and action of uremic toxins leading to endothelial damage and dysfunction of blood-brain barrier. Involuntary movements in CKD include restless legs syndrome (RLS), myoclonus, asterixis, dystonia, chorea, tremor, and Parkinsonism.

Conclusions: Chronic kidney disease can cause several abnormal involuntary movements via damaging basal ganglia and subcortical structures. The most common movement disorders in CKD are RLS, myoclonus and asterixis. Restless legs syndrome and myoclonus when severe, need and respond to treatment. Movement disorders in CKD improve with improvement of kidney function.

Citing Articles

Chorea in Hemodialysis Patients: Report of Two Cases.

Chen X, Zhang Y, Zhou Y Int J Nephrol Renovasc Dis. 2024; 17:301-306.

PMID: 39634782 PMC: 11616423. DOI: 10.2147/IJNRD.S490816.


Around-Body Versus On-Body Motion Sensing: A Comparison of Efficacy Across a Range of Body Movements and Scales.

Rohrer K, De Anda L, Grubb C, Hansen Z, Rodriguez J, St Pierre G Bioengineering (Basel). 2024; 11(11.

PMID: 39593825 PMC: 11591895. DOI: 10.3390/bioengineering11111163.


Flapping Tremor: Unraveling Asterixis-A Narrative Review.

Rissardo J, Muhammad S, Yatakarla V, Vora N, Paras P, Caprara A Medicina (Kaunas). 2024; 60(3).

PMID: 38541088 PMC: 10972428. DOI: 10.3390/medicina60030362.


Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease-Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows.

Martin-Virgala J, Martin-Carro B, Fernandez-Villabrille S, Ruiz-Torres M, Gomez-Alonso C, Rodriguez-Garcia M Int J Mol Sci. 2024; 25(3).

PMID: 38339121 PMC: 10855561. DOI: 10.3390/ijms25031843.


Myoclonus: Differential diagnosis and current management.

Riva A, DOnofrio G, Ferlazzo E, Pascarella A, Pasini E, Franceschetti S Epilepsia Open. 2024; 9(2):486-500.

PMID: 38334331 PMC: 10984309. DOI: 10.1002/epi4.12917.